therapeutics
Mubadala and QIA invests in Iambic Therapeutics $50 million funding round
Iambic Therapeutics, a clinical-stage biotechnology company developing novel therapeutics using its unique AI-driven discovery platform, oversubscribed the $50 million extension to its Series B financ...